Document Detail


Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the cardiac arrhythmia suppression trial (CAST).
MedLine Citation:
PMID:  10761807     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Clinical and demographic determinants of heart rate variability (HRV), an almost universal predictor of increased mortality, have not been systematically investigated in patients post myocardial infarction (MI). HYPOTHESIS: The study was undertaken to evaluate the relationship between pretreatment clinical and demographic variables and HRV in the Cardiac Arrhythmia Suppression Trial (CAST). METHODS: CAST patients were post MI and had > or =6 ventricular premature complexes/h on pretreatment recording. Patients in this substudy (n = 769) had usable pretreatment and suppression tapes and were successfully randomized on the first antiarrhythmic treatment. Tapes were rescanned; only time domain HRV was reported because many tapes lacked the calibrated timing signal needed for accurate frequency domain analysis. Independent predictors of HRV were determined by stepwise selection. RESULTS: Coronary artery bypass graft surgery (CABG) after the qualifying MI was the strongest determinant of HRV. The markedly decreased HRV associated with CABG was not associated with increased mortality. Ejection fraction and diabetes were also independent predictors of HRV. Other predictors for some indices of HRV included beta-blocker use, gender, time from MI to Holter, history of CABG before the qualifying MI, and systolic blood pressure. Decreased HRV did not predict mortality for the entire group. For patients without CABG or diabetes, decreased standard deviation of all NN intervals (SDANN) predicted mortality. Clinical and demographic factors accounted for 31% of the variance in the average of normal-to-normal intervals (AVGNN) and 13-26% of the variance in other HRV indices. CONCLUSIONS: Heart rate variability post MI is largely independent of clinical and demographic factors. Antecedent CABG dramatically reduces HRV. Recognition of this is necessary to prevent misclassification of risk in patients post infarct.
Authors:
P K Stein; P P Domitrovich; R E Kleiger; K B Schechtman; J N Rottman
Related Documents :
22771877 - Repaired tetralogy of fallot: ratio of right ventricular volume to left ventricular vol...
10980217 - Effects of spironolactone on heart rate variability and left ventricular systolic funct...
181977 - Cardiac dysrhythmias in the conscious dog after surgically induced autonomic imbalance.
16923007 - The role of heart rate variability in prognosis for different modes of death in chronic...
1462897 - Adenosine is an endogenous protectant against stunning during repetitive ischemic episo...
6456087 - The high-risk angina patient. identification by clinical features, hospital course, ele...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Clinical cardiology     Volume:  23     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-05-12     Completed Date:  2000-05-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  187-94     Citation Subset:  IM    
Affiliation:
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anti-Arrhythmia Agents / therapeutic use
Arrhythmias, Cardiac / etiology,  prevention & control
Coronary Artery Bypass
Diabetic Angiopathies / physiopathology
Female
Heart Rate*
Humans
Male
Middle Aged
Myocardial Infarction / complications,  mortality,  physiopathology*,  surgery
Predictive Value of Tests
Stroke Volume
Survival Analysis
Grant Support
ID/Acronym/Agency:
R0-3 HL53776/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Changes of QT dispersion in patients with coronary artery disease dependent on different methods of ...
Next Document:  Implantable cardioverter defibrillator discharge rates in patients with unexplained syncope, structu...